HDFC Pharma and Healthcare Fund
The fund maintains a concentrated bet on Indian pharmaceuticals, with nearly 71% deployed in the sector's established players like Divis and Sun Pharma, while healthcare services holdings like Max and Aster provide diversification. The manager added Cipla and trimmed Sun Pharma's overweight position, signaling a rebalancing toward broader pharma exposure rather than picking winners within the space. With nearly 60% in the top ten holdings, this remains a conviction-driven portfolio suited to investors bullish on India's healthcare sector but sensitive to individual stock risk.
Portfolio analysis · April 2026
NAV & Returns
| Plan | NAV | 1M | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|
| Primary | ₹19.2750 | +8.63% | +19.83% | — | — |
Portfolio Metrics(latest month)
vs Category Peers
Highly DifferentiatedActive Share = ½Σ|wfund − wpeer|, computed using leave-one-out peer portfolio within SEBI category.
Similar Funds in Category
What Changed2026-03-31 → 2026-04-30
| Stock | Weight |
|---|---|
| Cipla Ltd. | 4.27% |
| Cohance Lifesciences Limited | 0.56% |
| Novartis India Ltd. | 0.10% |
Full Holdings
| # | Holding | % to NAV |
|---|---|---|
| 1 | Divis Laboratories Ltd. INE361B01024 | 8.56% |
| 2 | Sun Pharmaceutical Industries Ltd. INE044A01036 | 8.05% |
| 3 | Lupin Ltd. INE326A01037 | 6.07% |
| 4 | Glenmark Pharmaceuticals Ltd. INE935A01035 | 6.06% |
| 5 | Max Healthcare Institute Limited INE027H01010 | 5.93% |
| 6 | Aster DM Healthcare Limited INE914M01019 | 5.46% |
| 7 | Alkem Laboratories Ltd. INE540L01014 | 4.69% |
| 8 | Anthem Biosciences Limited INE0CZ201020 | 4.55% |
| 9 | Ipca Laboratories Ltd. INE571A01038 | 4.39% |
| 10 | Cipla Ltd. INE059A01026 | 4.27% |
| 11 | Acutaas Chemicals Limited INE00FF01025 | 4.07% |
| 12 | Fortis Healthcare Limited INE061F01013 | 3.71% |
| 13 | Krishna Institute Of Medical Sciences Limited INE967H01025 | 3.04% |
| 14 | Laurus Labs Ltd. INE947Q01028 | 2.80% |
| 15 | Vijaya Diagnostic Centre Limited INE043W01024 | 2.55% |
| 16 | Metropolis Healthcare Ltd. INE112L01020 | 2.39% |
| 17 | Global Health Limited INE474Q01031 | 2.21% |
| 18 | Torrent Pharmaceuticals Ltd. INE685A01028 | 2.13% |
| 19 | Shilpa Medicare Ltd INE790G01031 | 2.04% |
| 20 | Neuland Laboratories Limited INE794A01010 | 1.97% |
Sector Allocation
Top 10 sectors by % to NAV. Excludes derivatives.
Frequently Asked Questions
How many stocks does HDFC Pharma and Healthcare Fund hold?
HDFC Pharma and Healthcare Fund holds 31 stocks as per the latest AMFI portfolio disclosure. The top 5 positions account for 34.67% of NAV.
What is the largest holding in HDFC Pharma and Healthcare Fund?
The largest position in HDFC Pharma and Healthcare Fund is Divis Laboratories Ltd., accounting for 8.56% of NAV in the Pharmaceuticals & Biotechnology sector.
Is HDFC Pharma and Healthcare Fund a concentrated or diversified fund?
With a Gini coefficient of 0.380, HDFC Pharma and Healthcare Fund is well-diversified. The HHI concentration index is 45,076 bps, which is above the 2500 bps threshold for high concentration. The top 5 holdings together make up 34.67% of the portfolio.
What is the market cap allocation of HDFC Pharma and Healthcare Fund?
Based on SEBI's AMFI classification, HDFC Pharma and Healthcare Fund's equity portfolio is split as: Large Cap: 28.94%, Mid Cap: 34.48%, Small Cap: 33.88%. This reflects the fund's positioning within the market cap spectrum.
Which sectors does HDFC Pharma and Healthcare Fund invest in most?
HDFC Pharma and Healthcare Fund has the highest allocation to Pharmaceuticals & Biotechnology (70.09%), Healthcare Services (26.62%), Healthcare Equipment & Supplies (0.59%). The fund is invested across 3 sectors in total.
How actively managed is HDFC Pharma and Healthcare Fund compared to other Sectoral / Thematic funds?
HDFC Pharma and Healthcare Fund has an Active Share of 90.64%, classifying it as "Highly Differentiated" among 237 Sectoral / Thematic peers. This means the fund takes significantly different stock positions compared to its category peers.
What changed in HDFC Pharma and Healthcare Fund's portfolio in the latest month?
Between 2026-03-31 and 2026-04-30, HDFC Pharma and Healthcare Fund added 3 new stocks (including Cipla Ltd.) and exited 1 stock (including Dr. Lal Path Labs Ltd). Total holding count increased from 31 to 33 stocks.